Benzinga's Top #PreMarket Gainers

NeuroDerm Ltd. NDRM shares jumped 18.93% to $7.35 in pre-market trading after the company reported topline results of Phase IIa pharmacokinetic study of ND0612H And ND0612L. Xenoport, Inc. XNPT shares jumped 11.78% to $9.30 in pre-market trading following positive comments from RBC's Michael Yee. Repros Therapeutics Inc. RPRX shares rose 6.80% to $10.36 in pre-market trading. Repros Therapeutics initiated two Phase 2B uterine fibroid studies. The company is expecting dossier to be filed by end of first quarter. American Realty Capital Properties, Inc. ARCP shares surged 6.13% to $9.00 in pre-market trading following the disclosure of a 7.1% stake by Corvex and confirmation of discussions with the company. OncoGenex Pharmaceuticals, Inc. OGXI shares gained 5.99% to $2.30 in the pre-market trading session as the company announced that it will regain rights to custirsen from Teva Pharmaceutical Industries Ltd. TEVA.